메뉴 건너뛰기




Volumn 41, Issue 4, 2006, Pages 1299-1302

Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein

Author keywords

Accelerator mass spectrometry; Anti TGF 1 monocloncal antibody; ELISA; Radiolabelled protein; Therapeutic protein

Indexed keywords

CARBON 14; METELIMUMAB; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

EID: 33646823282     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.02.019     Document Type: Article
Times cited : (15)

References (11)
  • 1
    • 33646822702 scopus 로고    scopus 로고
    • Biopharmaceutical product approval times dropped 21% since the 1980s according to Tufts CSDD. Tufts Center for the Study of Drug Development, 11 March 2003. http://csdd.tufts.edu/.
  • 3
  • 9
    • 67649395716 scopus 로고    scopus 로고
    • Ultra-sensitive detection of radiolabelled drugs and their metabolites using accelerator mass spectrometry
    • Wilson I. (Ed), Elsevier Science, Amsterdam
    • Lappin G., and Garner R.C. Ultra-sensitive detection of radiolabelled drugs and their metabolites using accelerator mass spectrometry. In: Wilson I. (Ed). Handbook of Bioanalytical Separations (2003), Elsevier Science, Amsterdam 331-349
    • (2003) Handbook of Bioanalytical Separations , pp. 331-349
    • Lappin, G.1    Garner, R.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.